# Vanda Pharmaceuticals Inc.: Form 8-K, filed Oct 3, 2024

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: 8-K
- Filed: 2024-10-03
- Accepted by EDGAR: Oct 3, 2024, 17:00 ET
- Period: 2024-10-02
- Accession: 0001193125-24-232306
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000119312524232306/d828148d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000119312524232306/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000119312524232306/d828148d8k.htm

Filed Oct 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-232306. Last ingested by Listed: Nov 14, 2026, 11:42 ET. No prices; not investment advice.
